These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 15225884

  • 41. Gamma-hydroxybutyrate (GHB): a new drug of misuse.
    Williams H, Taylor R, Roberts M.
    Ir Med J; 1998; 91(2):56-7. PubMed ID: 9617031
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Alcohol withdrawal syndrome: how to predict, prevent, diagnose and treat it.
    Prescrire Int; 2007 Feb; 16(87):24-31. PubMed ID: 17323538
    [Abstract] [Full Text] [Related]

  • 45. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).
    Wood DM, Warren-Gash C, Ashraf T, Greene SL, Shather Z, Trivedy C, Clarke S, Ramsey J, Holt DW, Dargan PI.
    QJM; 2008 Jan; 101(1):23-9. PubMed ID: 18203723
    [Abstract] [Full Text] [Related]

  • 46. Fatality due to gamma-hydroxybutyric acid (GHB) and heroin intoxication.
    Ferrara SD, Tedeschi L, Frison G, Rossi A.
    J Forensic Sci; 1995 May; 40(3):501-4. PubMed ID: 7782758
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Evaluation for the withdrawal syndrome from gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines.
    Quang LS, Colombo G, Lobina C, Maccioni P, Orru A, Gessa GL, Maher TJ, Carai MA.
    Ann N Y Acad Sci; 2006 Aug; 1074():545-58. PubMed ID: 17105952
    [Abstract] [Full Text] [Related]

  • 51. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome.
    Busardò FP, Kyriakou C, Napoletano S, Marinelli E, Zaami S.
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4654-63. PubMed ID: 26698265
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. gamma-Hydroxybutyrate withdrawal and chloral hydrate.
    Hutto B, Fairchild A, Bright R.
    Am J Psychiatry; 2000 Oct; 157(10):1706. PubMed ID: 11007738
    [No Abstract] [Full Text] [Related]

  • 56. [Course and complications of GHB detoxification treatment: a 1-year case series].
    Neu P.
    Nervenarzt; 2019 May; 90(5):509-515. PubMed ID: 30362026
    [Abstract] [Full Text] [Related]

  • 57. Adverse events, including death, associated with the use of 1,4-butanediol.
    Zvosec DL, Smith SW, McCutcheon JR, Spillane J, Hall BJ, Peacock EA.
    N Engl J Med; 2001 Jan 11; 344(2):87-94. PubMed ID: 11150358
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.